The retrospective cohort study included more than 130,000 people in the US. It reveals that the shingles vaccine (called ...

The US Food and Drug Administration (FDA) has approved GSK's Shingrix vaccine (recombinant zoster vaccine or RZV) in a ...

This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for ...

Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's blockbuster shingles vaccine Shingrix, ...

Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

One major reason why the U.S. and Western Europe have seen dramatic population increase over the last 200-plus years, Aaby ...

Shingrix's manufacturer, GlaxoSmithKline, didn't anticipate it would be so popular when it first hit the market. In the first six months of 2018 alone, more doses of Shingrix were administered in ...

The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster ...